107 related articles for article (PubMed ID: 28435076)
1. Design, synthesis, biological evaluation and molecular modelling of 2-(2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2H)-ones: A novel class of TSPO ligands modulating amyloid-β-induced mPTP opening.
Elkamhawy A; Park JE; Hassan AHE; Pae AN; Lee J; Park BG; Paik S; Do J; Park JH; Park KD; Moon B; Park WK; Cho H; Jeong DY; Roh EJ
Eur J Pharm Sci; 2017 Jun; 104():366-381. PubMed ID: 28435076
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of G3139 and TSPO ligands on Ca(2+)-induced permeability transition in rat brain mitochondria.
Azarashvili T; Krestinina O; Baburina Y; Odinokova I; Grachev D; Papadopoulos V; Akatov V; Lemasters JJ; Reiser G
Arch Biochem Biophys; 2015 Dec; 587():70-7. PubMed ID: 26498031
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction.
Elkamhawy A; Park JE; Hassan AHE; Ra H; Pae AN; Lee J; Park BG; Moon B; Park HM; Roh EJ
Eur J Med Chem; 2017 Mar; 128():56-69. PubMed ID: 28152427
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 2-(3-arylureido)pyridines and 2-(3-arylureido)pyrazines as potential modulators of Aβ-induced mitochondrial dysfunction in Alzheimer's disease.
Elkamhawy A; Park JE; Hassan AHE; Pae AN; Lee J; Park BG; Roh EJ
Eur J Med Chem; 2018 Jan; 144():529-543. PubMed ID: 29288949
[TBL] [Abstract][Full Text] [Related]
5. Effect of the CRAC Peptide, VLNYYVW, on mPTP Opening in Rat Brain and Liver Mitochondria.
Azarashvili T; Krestinina O; Baburina Y; Odinokova I; Akatov V; Beletsky I; Lemasters J; Papadopoulos V
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983605
[TBL] [Abstract][Full Text] [Related]
6. Pyrazinyl ureas revisited: 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of Aβ-induced mPTP opening for Alzheimer's disease.
Elkamhawy A; Park JE; Hassan AHE; Pae AN; Lee J; Paik S; Park BG; Roh EJ
Eur J Med Chem; 2018 Sep; 157():268-278. PubMed ID: 30098482
[TBL] [Abstract][Full Text] [Related]
7. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells.
Zeno S; Zaaroor M; Leschiner S; Veenman L; Gavish M
Biochemistry; 2009 Jun; 48(21):4652-61. PubMed ID: 19358520
[TBL] [Abstract][Full Text] [Related]
8. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine.
Kugler W; Veenman L; Shandalov Y; Leschiner S; Spanier I; Lakomek M; Gavish M
Cell Oncol; 2008; 30(5):435-50. PubMed ID: 18791274
[TBL] [Abstract][Full Text] [Related]
9. Discovery of benzimidazole derivatives as modulators of mitochondrial function: A potential treatment for Alzheimer's disease.
Kim T; Yang HY; Park BG; Jung SY; Park JH; Park KD; Min SJ; Tae J; Yang H; Cho S; Cho SJ; Song H; Mook-Jung I; Lee J; Pae AN
Eur J Med Chem; 2017 Jan; 125():1172-1192. PubMed ID: 27855359
[TBL] [Abstract][Full Text] [Related]
10. Carbenoxolone induces permeability transition pore opening in rat mitochondria via the translocator protein TSPO and connexin43.
Azarashvili T; Baburina Y; Grachev D; Krestinina O; Papadopoulos V; Lemasters JJ; Odinokova I; Reiser G
Arch Biochem Biophys; 2014 Sep; 558():87-94. PubMed ID: 24995971
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity.
Park JE; Elkamhawy A; Hassan AHE; Pae AN; Lee J; Paik S; Park BG; Roh EJ
Eur J Med Chem; 2017 Dec; 141():322-334. PubMed ID: 29031076
[TBL] [Abstract][Full Text] [Related]
12. Novel quinazoline-urea analogues as modulators for Aβ-induced mitochondrial dysfunction: design, synthesis, and molecular docking study.
Elkamhawy A; Lee J; Park BG; Park I; Pae AN; Roh EJ
Eur J Med Chem; 2014 Sep; 84():466-75. PubMed ID: 25050879
[TBL] [Abstract][Full Text] [Related]
13. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
Veenman L; Papadopoulos V; Gavish M
Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
Taliani S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells.
Qu M; Zhou Z; Chen C; Li M; Pei L; Yang J; Wang Y; Li L; Liu C; Zhang G; Yu Z; Wang D
Neurosci Res; 2012 Jan; 72(1):94-102. PubMed ID: 22001761
[TBL] [Abstract][Full Text] [Related]
16. Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection.
Wu Y; Kazumura K; Maruyama W; Osawa T; Naoi M
J Neural Transm (Vienna); 2015 Oct; 122(10):1399-407. PubMed ID: 25863936
[TBL] [Abstract][Full Text] [Related]
17. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
Veenman L; Gavish M
Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
[TBL] [Abstract][Full Text] [Related]
18. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
[TBL] [Abstract][Full Text] [Related]
19. 4'-Chlorodiazepam is neuroprotective against amyloid-beta through the modulation of survivin and bax protein expression in vitro.
Arbo BD; Marques CV; Ruiz-Palmero I; Ortiz-Rodriguez A; Ghorbanpoor S; Arevalo MA; Garcia-Segura LM; Ribeiro MF
Brain Res; 2016 Feb; 1632():91-7. PubMed ID: 26707976
[TBL] [Abstract][Full Text] [Related]
20. Guwiyang Wurra--'Fire Mouse': a global gene knockout model for TSPO/PBR drug development, loss-of-function and mechanisms of compensation studies.
Middleton RJ; Liu GJ; Banati RB
Biochem Soc Trans; 2015 Aug; 43(4):553-8. PubMed ID: 26551692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
